Abstract
Introduction
Silent cerebral ischemia (SCI) observed on diffusion-weighted magnetic resonance imaging (DW MRI) as a complication of atrial fibrillation (AF) ablation has been reported at varying rates [1] [2] [3] [4] [5] [6] [7] and generated significant concern regarding the long-term consequences of these procedures. The diagnosis of SCI is based on the comparison of two cerebral DWI MRI examinations, usually performed 48-72 h apart with the AF ablation procedure carried out between them. This imaging modality provides no intra-procedural data which would suggest the mechanism of lesion formation. In contrast, bilateral insonation of the middle cerebral artery (MCA) using transcranial Doppler (TCD) offers a real-time assessment of micro--embolization throughout the whole procedure. The use of TCD during AF ablation was first reported by Kilicaslan et al. [8] , who found a significant relationship between the number of micro-embolic signals (MESs) on TCD and clinical stroke events. The present group has demonstrated that the majority of MESs are gaseous and the generation of micro-emboli is concentrated in the phase of energy delivery with some ablation techniques [9, 10] . Further, the site of ablation, the ongoing rhythm and certain biophysical parameters during phased radiofrequency (RF) ablation have been found to be predictive of the rate of microembolization [11, 12] .
This was prospectively investigated and the rate of micro-embolization during pulmonary vein isolation (PVI) and the incidence of new postablation cerebral lesions on DW MRI in patients undergoing PVI with phased RF and the pulmonary vein ablation catheter (PVAC) was reported.
Methods

Study population
Consecutive patients undergoing PVI with the PVAC and the GENius TM 14.4 RF generator for symptomatic paroxysmal or persistent, but not long-standing persistent AF not adequately controlled by at least one antiarrhythmic drug were considered for enrollment in the study. All these patients were asked to consent to continuous, bilateral TCD detection during the ablation procedure, and to DW MRI examinations before and after PVI. Standard exclusion criteria including hyper-or hypothyroidism, heart failure, left atrial (LA) diameter exceeding 50 mm and previous clinical ischemic stroke or transient ischemic attack were applied. The study design conformed with the guiding principles of the Declaration of Helsinki, and was approved by the Institutional Ethics Committee.
Ablation procedure
Patients were hospitalized 1 or 2 days before the procedure. Transesophageal echocardiography was carried out within 24 h prior to the procedure in order to rule out the presence of a cardiac thrombus. All procedures were performed on uninterrupted vitamin K antagonist therapy with a target international normalized ratio of 2.0 to 3.0, which was confirmed on the day of the ablation. The ablation protocol was reported earlier [10] [11] [12] . In brief, under conscious sedation, decapolar and quadripolar catheters were advanced from the femoral vein and positioned in the coronary sinus and the right ventricle. Immediately before transseptal puncture, a 150 IU/kg body weight i.v. heparin bolus was given, followed by a continuous infusion and additional 2000-5000 IV i.v. boluses of heparin were administered if needed to reach a target activated clotting time (ACT) level of 350 s. The ACT was always checked prior to the first ablation and every 20 min thereafter. RF delivery was not started until the ACT reached at least 300 s. A single trans-septal puncture was performed under fluoroscopic and intra-cardiac echocardiographic guidance, using a standard technique and an 8.5 F SL0 Swartz sheath (St Jude Medical, Minnetonka, MN, USA). This sheath was then exchanged for a deflectable 65-cm-long sheath with a 12-Fr inner lumen (FlexCath, Medtronic CryoCath LP, Kirkland, Quebec, Canada) to be used as a guide for the PVAC (Ablation Frontiers, Medtronic, Carlsbad, CA, USA). The distal circular segment of the PVAC was captured under saline before introduction into the sheath in order to eliminate any microbubbles possibly entrapped between the electrode arrays.
The PVAC was positioned consecutively at the ostia of each pulmonary vein (PV). The proper position was assessed before the first RF delivery at each PV by means of a hand-held injection (8-10 mL) of contrast medium (Optiray, Covidien Deutschland GmbH, Germany) diluted with saline in a 1:1 ratio through the FlexCath sheath, which was positioned close to the anticipated PV ostium. The saline infusion used for continuous flushing of the FlexCath sheath was interrupted for PV angiography and meticulous care was taken to eliminate any air bubbles in the sheath and in the syringe before contrast injections.
Once the optimal catheter position has been confirmed RF energy was applied in a 2:1 bipolar/ /unipolar mode for 60 s, usually 3-4 times per PV. Simultaneous RF energy delivery to PVAC electrodes 1 (E1) and 10 (E10) was initiated only after careful fluoroscopic assessment of their positions when the inter-electrode distance appeared at least twice the fixed distance between two other adjacent electrodes. The electrode position was checked periodically during RF delivery. Any electrode pair that failed to reach a minimum of 50 o C during RF delivery was switched off. RF delivery was also discontinued to electrodes after having reached the target temperature while delivering very low power (1-2 W).
The procedural endpoint was electrical isolation of all PVs, as confirmed by an entrance block evidenced by the disappearance of PV potentials is sinus rhythm, during coronary sinus pacing or during AF. No electrical cardioversion had been performed during the procedure or in the earlypost-ablation period before repeat cerebral MRI was completed. Heparin was discontinued at the end of the procedure with no protamine administered and the venous sheaths were removed 4-6 h later.
TCD recording and evaluation
Transcranial Doppler recording was performed throughout the whole period of LA access. The transducer was held in place by a proprietary headpiece supplied with the system. The MCAs were bilaterally insonated from trans-temporal windows by using a multi-frequency Doppler (Multi Dop T digital, DWL, QL software 2.8) which insonates simultaneously with frequencies of 2 MHz and 2.5 MHz. The system is capable of the automatic online identification of true MESs with a sensitivity of 100% and a specificity of 99.3% and it also distinguishes between gaseous and solid emboli with a specificity of 96.5% [13, 14] . TCD parameter settings were as recommended by the consensus criteria [15] and were kept constant during the procedures. The insonation depth was 45-55 mm, the sample volume was 8 mm, and the power was 60-100 mW. MES counts were collected and evaluated separately during the different stages of the procedure as follows: -trans-septal puncture: the 30-s period after crossing the interatrial septum with the transseptal needle; -PV angiography: contrast injection through the FlexCath trans-septal sheath. MESs were counted until they gradually decreased and disappeared after a marked burst, which usually followed the bolus within 5-10 s; -energy delivery: from the start until 15 s after termination of energy delivery; -the remainder of the procedure: that part of LA access period during which none of the aforementioned maneuvers were performed. As bilateral recording was technically not possible in all patients, MES counts were calculated as mean MES count per patient, using either the mean of the bilateral counts when both sides were measured, or the unilateral data when only one side was available.
Cerebral MRI
Cerebral MRI was performed the day before and within 48 h after the procedure using a GE Sigma Excite 1.5 T (GE Medical Systems, Milwaukee, USA) scanner and an 8-channel phased array head coil. A routine brain imaging protocol was performed, including anaxial diffusion-weighted DW MRI data were analyzed by two radiology experts blinded to the clinical status of the patients. The pre-procedure MRI was compared with the post-procedure MRI to identify any new procedure-related acute cerebral lesion defined as a focal hyper-intense area detected on the DWI confirmed by apparent diffusion coefficient mapping to rule out a shine-through artifact. The size and localization of focal diffusion abnormalities were analyzed. For patients who were positive for a new DWI lesion in the post-procedure MRI, another follow-up MRI was performed 3-month post-ablation.
Statistical analysis
Complete data sets for all patients were collected, including the results of intra-procedural TCD monitoring, pre-and post-ablation DW MRI. Patient and procedural characteristics were evaluated by using means and standard deviation (SD) or medians and interquartile range (IQR) for continuous variables accordingly, and counts and percentages for categorical variables. Groups of patients with and without DW MRI lesions were descriptively compared in terms of MES counts using Wilcoxon's rank-sum test. Logistic regression was used to evaluate the adjusted relationship between MES count and lesion development. Age was used as an apriori adjustment factor. Other potential explanatory variables were assessed for inclusion in the model. To improve distribution normality, age was cubic transformed, and the total MES count per MCA was natural log transformed. As curvature was observed in the relationship, a squared term for the log MES count was also used. Interactions were detected between the log MES count and age cubed, and between the squared log MES count and age cubed, and were therefore, included in the model. The effects of the MES count were expressed by comparing the odds for lesion development at a MES count of 1500 (a value close to the sample 75 th percentile) to that at a count of 1100 (close to the sample median) in terms of odds ratios and 95% confidence intervals, specifically for levels across the range of age within which lesion development was observed. Model checking was based on the Hosmer-Lemeshow goodness of fit test.
Results
Patient and procedural characteristics
A total of 36 consecutive patients who underwent PVI with the PVAC and the GENius 14.4 generator gave consent to pre-and post-ablation cerebral MRI and to intra-procedural TCD monitoring. Two patients withdrew their consents from post-ablation MRI. TCD recording of MESs with sufficient quality could not be achieved in 7, thereby the full data sets of 27 patients were available for analysis (Table 1) .
A total of 108 PVs were successfully isolated. The mean (SD) procedure and fluoroscopy times were 106 (27.1) min and 23 (10), respectively. Procedural complications included 1 case of pericardial tamponade which required pericardiocentesis. Clinical stroke did not occur in any of the patients during or within 1 month after the ablation.
TCD and MRI results
The median (IQR) MES count per patient was 1151 (584). The highest rate of micro-embolization in any stage of the procedure was recorded during RF delivery (Fig. 1 ) and the majority of the MESs were gaseous during all phases of data collection (Fig. 2) .
New SCI on DW MRI after PVI was demonstrated in 6 (22%) patients: a single lesion in 2, two lesions in 3, and three lesions in 1 case ( Table 2) . The average (SD) lesion diameter was 7.05 (2.9) mm (4.1-13.4 mm). The majority of these lesions had disappeared by the 3-month follow-up: 1 patient had only a single lesion still detectable with a significant size reduction, and no new lesion as compared with the post-ablation image was demonstrated in any patient.
Several clinical parameters were investigated as possible predictors for SCI, including age, gender, LA diameter, left ventricular ejection fraction, CHA 2 DS 2 -VASC score, lacunary infarction on the preablation MRI, the total energy delivery time, the number of contrast injections during theprocedure, the percentage of concomitant use of E1/E10 and the mean intra-procedural ACT (Table 3 ). There was no significant difference among baseline clinical parameters between patients with and without new SCI.
Association between micro-embolization and MRI lesions
Comparative analysis between TCD and MRI results are shown in Table 4 . The total median (Table 5) .
Discussion
According to available research, this is the first study that has assessed the relationship between post-ablation SCI on DW MRI and the number of micro-emboli detected by TCD during PVI. A higher total MES count recorded during findings. Nonetheless, the relationship between the total MES count and SCI among the older patients was significant, suggesting that not only a micro-embolic load to the brain, but also the status of the cerebral vasculature might be relevant in lesion formation. Reduction of micro-embolus generation to the lowest possible level therefore seems especially important in the elderly, and it should be considered when selecting the ablation technique in this patient cohort. Further, additional risk of SCI has to be considered in these patients. The MES count recorded during PV angiography proved to be a significant predictor of new cerebral lesions in this study. As the number of micro-emboli recorded during PV angiography comprises only a relatively small fraction of the total MES count recorded throughout the entire procedure, the strong correlation with SCI was somewhat unexpected. Although the majority are gaseous, similarly to those recorded during other phases of the procedure, the physical characteristics of MESs generated during contrast injections may differ. Moreover, PV angiography involves the injection of rapid boluses of contrast material into systemic circulation, and micro-emboli, although relatively small in number, are thereby, introduced within a very short time. It may be speculated that, besides the number of micro-emboli, the intensity of these micro-embolic showers reaching the brain circulation might also be an important determinant of lesion formation.
The present results are in line with recent data published from the Mayo Clinic. In an elegant in vivo pig model Takami et al. [16] performed different catheter, sheath manipulations and ablations while measuring micro-embolization using intracardiac echocardiography, Carotid Doppler, and an extra-corporal circulation loop which included a microbubble counter and blood filters to collect particulas. Significant microbubble formation was demonstrated on ICE, Carotid Doppler and in the loop during PV angiography and sheath flushing at a high flow, while micro-particles were mostly found during catheter dragging and after a steam pop. The present findings in patients appear to support these experimental data and may well have important practical implications as around half of the ablation centers worldwide [17] routinely perform PV angiography during PVI.
Importantly, the definition presented here of SCI was any new finding concerning the DW sequence with or without FLAIR positivity. This is different from the definitions used in most other studies [1, 2, 6, 7] . This more sensitive criterion was chosen to enable consideration of any detectable brain ischemia for comparison with MES data. FLAIR positivity was found in 5 of 6 patients and in 6 of 11 lesions in our study, and the majority of the lesions had resolved by the 3-month follow-up.
Although the aim of this research was to assess the relationship between TCD and DW MRI findings and not to evaluate the safety of phased RF ablation, it is noteworthy that lower incidences of SCI have been found in recent multi-center studies [18, 19] . This favorable trend has been attributed to procedural modifications of phased RF ablation based on the results of clinical and preclinical studies [20, 21] . RF delivery to electrodes 1 and 10 getting close to each other due to a wedge position of the PVAC loop has been identified as the most significant contributor to embolus generation due to high current density, therefore simultaneous energization of these electrodes was prohibited in these trials and electrode 10 was even being removed from the novel PVAC Gold. Concomitant RF application on poles 1 and 10 was however not a priori excluded in the present study, and only when the inter-electrode distance on fluoroscopy was considered unsafe. Nonetheless, this more "liberal" practice did not contribute to a higher incidence of SCI lesions in this study.
The importance of SCI after AF ablation remains unclear. The concern that these lesions might be related to cognitive decline is supported by limited data [22, 23] . It has also been suggested that these lesions might be viewed as surrogates for the clinical stroke risk and are useful for an assessment of the risk involved with different ablation techniques and procedural changes [24] . The present data does suggest that TCD detection during LA ablation might improve our understanding of the micro-embolization process during these procedures.
Limitations of the study
The most important limitation of this study is the relatively small number of patients, and especially the low number of those with a new lesion on DW MRI after ablation. This exemplifies the challenges of enrolling patients that require nonstandard of care MRIs and the technical difficulties of TCD examination during relatively longer procedures in some patients. Although these observations reduced the power of the statistical analysis, a strong relationship between SCI and the MES count recorded during PV angiography was still demonstrated. Importantly, PVI was performed using phased RF exclusively in this study. Future studies with similar design but with different ablation technologies (cryoballoon, focal irrigated RF) might therefore be of interest.
Conclusions
This study demonstrates a relationship between micro-embolization detected by TCD over the MCA and acute SCI on DW MRI after PVI with phased radiofrequency and the pulmonary vein ablation catheter. Higher numbers of micro-emboli detected during pulmonary vein angiography were predictive of positive postablation findings on DW MRI.
